Literature DB >> 32644098

Cancer Survivorship-Considering Mindsets.

Lauren C Heathcote1, Sean R Zion2, Alia J Crum2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32644098      PMCID： PMC7644142          DOI： 10.1001/jamaoncol.2020.2482

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  5 in total

1.  Targeting Mindsets, Not Just Tumors.

Authors:  Sean R Zion; Lidia Schapira; Alia J Crum
Journal:  Trends Cancer       Date:  2019-10-05

Review 2.  Conditioning Immune and Endocrine Parameters in Humans: A Systematic Review.

Authors:  Judith Tekampe; Henriët van Middendorp; Stefanie H Meeuwis; Jelle W R van Leusden; Gustavo Pacheco-López; Ad R M M Hermus; Andrea W M Evers
Journal:  Psychother Psychosom       Date:  2017-02-10       Impact factor: 17.659

3.  Pain hypervigilance is associated with greater clinical pain severity and enhanced experimental pain sensitivity among adults with symptomatic knee osteoarthritis.

Authors:  Matthew S Herbert; Burel R Goodin; Samuel T Pero; Jessica K Schmidt; Adriana Sotolongo; Hailey W Bulls; Toni L Glover; Christopher D King; Kimberly T Sibille; Yenisel Cruz-Almeida; Roland Staud; Barri J Fessler; Laurence A Bradley; Roger B Fillingim
Journal:  Ann Behav Med       Date:  2014-08

4.  Cancer Survivorship-A Call to Action.

Authors:  Laurence H Baker
Journal:  JAMA Oncol       Date:  2020-05-01       Impact factor: 31.777

5.  Placebo effects mediated by endogenous opioid activity on mu-opioid receptors.

Authors:  Jon-Kar Zubieta; Joshua A Bueller; Lisa R Jackson; David J Scott; Yanjun Xu; Robert A Koeppe; Thomas E Nichols; Christian S Stohler
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167
  5 in total
  1 in total

Review 1.  Management and Thinking on the Treatment of Cancer Patients During the COVID-19.

Authors:  Shuangyue Pan; Jiahong Jiang; Zheling Chen; Liu Yang
Journal:  Front Mol Biosci       Date:  2021-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.